{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:01:29Z","timestamp":1789628489556,"version":"build-2803163510"},"reference-count":12,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2006,10,10]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> To search for subclinical systemic disease in bone marrow and peripheral blood in patients with primary CNS lymphoma (PCNSL) to elucidate whether extracerebral relapse may represent a sequel of initial occult systemic disease rather than true extracerebral spread. <\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p> Bone marrow and peripheral-blood specimens of 24 PCNSL patients were examined using polymerase chain reaction (PCR) for analysis of clonally rearranged immunoglobulin heavy-chain (IgH) genes. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Identical dominant PCR products were found in bone marrow aspirates, blood samples, and tumor biopsy specimens of two patients, indicating that the same tumor cell population is present in the CNS and in extracerebral sites. Follow-up IgH PCR performed in one of these patients in complete remission 24 months after diagnosis yielded a persistent monoclonal product in the blood. An oligoclonal IgH rearrangement pattern was found in the tumor specimen of two other patients, whereas bone marrow and blood samples demonstrated the same dominant PCR products. Follow-up PCR showed a persistent monoclonal amplificate in blood in one of these patients 27 months after diagnosis. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> It could be demonstrated for the first time that subclinical systemic disease can be present in PCNSL patients at initial diagnosis. Our findings may have an impact on the understanding of PCNSL pathogenesis and the extent of staging and treatment. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2006.06.7165","type":"journal-article","created":{"date-parts":[[2006,9,12]],"date-time":"2006-09-12T00:46:58Z","timestamp":1158022018000},"page":"4754-4757","source":"Crossref","is-referenced-by-count":71,"title":["Detection of Subclinical Systemic Disease in Primary CNS Lymphoma by Polymerase Chain Reaction of the Rearranged Immunoglobulin Heavy-Chain Genes"],"prefix":"10.1200","volume":"24","author":[{"given":"Kristoph","family":"Jahnke","sequence":"first","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Korfel","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Burmeister","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kiewe","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann Ayke","family":"Klasen","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Henning","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Stein","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology, Oncology, and Transfusion Medicine, and General Pathology and Reference Center for Hematopathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Benjamin Franklin, Berlin; and the Department of Radiation Therapy and Medical Oncology, Pius Hospital Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-11-199312010-00007"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.864"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1007\/BF01054724"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<827::AID-CNCR4>3.0.CO;2-B"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3314.bloodjournal8893314"},{"key":"R6","unstructured":"Kurokawa T, Kinoshita T, Ito T, et al: Detection of minimal residual disease B cell lymphoma by a PCR-mediated RNase protection assay. Leukemia 10:1222,1996-1231,"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2133030.x"},{"key":"R8","unstructured":"Jaffe ES, Harris NL, Stein H, et al: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues . Lyon, France, International Agency for Research on Cancer Press, 2001"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"R10","unstructured":"Sandberg Y, Heule F, Lam K, et al: Molecular immunoglobulin\/T-cell receptor clonality analysis in cutaneous lymphoproliferations: Experience with the BIOMED-2 standardized polymerase chain reaction protocol. Haematologica 88:659,2003-670,"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-1578(10)60591-0"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3804"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.06.7165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:21:36Z","timestamp":1653513696000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.06.7165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,10]]},"references-count":12,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2006,10,10]]}},"alternative-id":["10.1200\/JCO.2006.06.7165"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.06.7165","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,10]]}}}